BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 18, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Immunomedics preclinical data

In mouse xenograft models of non-Hodgkin's lymphoma (NHL) and multiple myeloma (MM), a single 1 µg dose of C2-2b-2b given 7 days after tumor...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >